Volume 20 No 13 (2022)
Download PDF
Clinical Manifestations of Lung Cancers A Prospective Observational Study
Dr. Salma Koser Bhat, Dr. Kalash Chander and Dr Abhishek Sharma
Abstract
Background: Since 1985, lung cancer has been diagnosed more frequently than any other type of
cancer. Lung cancer's clinical manifestations are caused by the tumor's local growth, regional growth or
lymphatic system dissemination, haematogenous distant metastatic spread, and remote paraneoplastic
effects. The majority of organs can be impacted by distant metastatic illness. The majority of individuals
had lung to lung metastases, brain metastasis, and bone metastasis. Aim: Clinical profile of patients of
Lung carcinoma in District Kathua of UT of J&K. Materials and methods : This study was a prospective
observational and one point analysis. The study group comprised of CA lung patients who were
admitted or presented to OPD in GMC Kathua. Results : A total of 54 patients were taken up for this
study. Majority of the patients were in the age group of 46 to 75 years. Metastatic pattern had been
observed in 42 patients. Among 42 patients having metastasis 42.8% had brain metastasis, 38.09%
patients had metastatic pleural/pericardial effusion, 11.9% patients had bone metastasis, 4.76%
patients showed lung to lung metastasis and rest of the patients presented with distant
metastasis.Conclusion: Mostly death in the lung cancer is due to the extra thoracic metastasis . When a
patient presents with a single tumor or multiple tumors, with or without known primary cancer,
clinicians should be alert to the possibility primary cancer metastases, and a biopsy of the suspicious
lesion should be obtained to aid the histological identification of primary cancer and various
radiological scans should be used as an effective tool for diagnosis and evaluation
Keywords
lung , cancer, metastatis
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.